Completed PHASE3 INTERVENTIONAL 2-arm NCT01073995

The Effectiveness of Selective Nerve Root Injections in Preventing the Need for Surgery

The Effectiveness of Selective Nerve Root Injections in Preventing the Need for Surgery in Patients With Lumbar Disc Herniations

Sponsor: Horizon Health Network

Conditions Radiculopathy

Interventions Kenalog and Sensorcaine

Updated 5 times since 2017 Last updated: Sep 28, 2016 Started: Mar 31, 2010 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Radiculopathy, this trial is completed. The trial is conducted by Horizon Health Network and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Horizon Health Network

Data source: Horizon Health Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint John, Canada